Director James T. LaFrance resigns; Dr. Robert Auerbach joins Audit Committee

Aspira Women's Health Inc.

James T. LaFrance resigned from the board of directors effective December 15, 2022.
Dr. Robert Auerbach appointed to the Audit Committee of the board.
Amendment corrects a typo: Minh Merchant is General Counsel/Corporate Secretary, not Interim CFO.
No other changes to the original Dec 21, 2022 8-K.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

James T. LaFrance

Director

AWHL · Aspira Women's Health Inc.

Effective: 2022-12-15
Filed: December 22, 2022, 6:59 PM ET

On December 15, 2022, James T. LaFrance resigned from the board of directors (the “ Board ”) of the Company, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

James T. LaFrance resigned as Director at Aspira Women's Health Inc..

Action: resigned
Role: Director

Exact text from the filing

On December 15, 2022, James T. LaFrance resigned from the board of directors (the “ Board ”) of the Company, effective immediately.

View on SEC.gov

Aspira Women's Health Inc. filing history →

Source: SEC EDGAR

accession 0000926617-22-000072

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.